US funding freeze linked to HIV care disruptions in 32 countries, study finds
Medical Xpress
February 25, 2026
AI-Generated Deep Dive Summary
A new study reveals that the U.S. foreign assistance freeze has significantly disrupted HIV care in 32 countries across sub-Saharan Africa and the Asia-Pacific region. Conducted by researchers from the CUNY Institute for Implementation Science in Population Health (ISPH) and published in *Health Affairs Scholar*, the research surveyed 76 HIV clinics, finding that nearly half experienced disruptions in services, medications, lab work, and clinic operations following the January 2025 funding halt. This study underscores the critical role of U.S. aid in global HIV response programs, particularly in regions heavily reliant on PEPFAR (President's Emergency Plan for AIDS Relief).
The freeze has immediate consequences, affecting not only treatment but also prevention efforts and testing services. Many clinics reported shortages of antiretroviral medications, leading to potential interruptions in care for thousands of patients. Additionally, reduced funding has strained already limited healthcare resources, forcing some facilities to cut staff or reduce operating hours. This situation highlights the broader impact on public health infrastructure and global health security.
The study also raises ethical concerns about the U.S.'s commitment to international health partnerships. With HIV remaining a significant global health challenge, particularly in low- and middle-income countries, continued support is crucial for maintaining progress toward global health goals. The findings emphasize the need for sustainable funding models and international collaboration to address such crises effectively.
This research serves as a stark reminder of the interconnectedness of global health systems and the importance of equitable resource distribution. As the world faces evolving
Verticals
healthmedical
Originally published on Medical Xpress on 2/25/2026